Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.64 |
| ▸ | NPC1 | O15118 | 2/20 | 0.64 |
| ▸ | RAB9A | P51151 | 2/20 | 0.64 |
| ▸ | GAA | P10253 | 2/20 | 0.64 |
| ▸ | RECQL | P46063 | 1/20 | 0.64 |
| ▸ | TP53 | P04637 | 1/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.64 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1829272 | 0.92 | MAPT (0.57) | MAPTCYP1A2SMN1; SMN2NPC1RAB9A | |
| SCHEMBL29509427 | 0.92 | KDM4E (0.68) | MAPTCYP1A2SMN1; SMN2NPC1RAB9A | |
| SCHEMBL1500410 | 0.92 | KDM4E (0.68) | MAPTCYP1A2SMN1; SMN2NPC1RAB9A | |
| SCHEMBL17276045 | 0.90 | MAPT (0.55) | MAPTCYP1A2SMN1; SMN2NPC1RAB9A | |
| Hydrochloric Acid SCHEMBL9426978 | 0.90 | KDM4E (0.65) | MAPTCYP1A2SMN1; SMN2NPC1RAB9A | |
| SCHEMBL9426972 | 0.90 | CYP1A2 (0.59) | MAPTCYP1A2SMN1; SMN2NPC1RAB9A | |
| SCHEMBL23037197 | 0.89 | MAPT (0.54) | MAPTCYP1A2SMN1; SMN2NPC1RAB9A | |
| SCHEMBL29595815 | 0.89 | MAPT (0.54) | MAPTCYP1A2SMN1; SMN2NPC1RAB9A | |
| SCHEMBL16845711 | 0.88 | MAPT (0.54) | MAPTCYP1A2SMN1; SMN2NPC1RAB9A | |
| SCHEMBL19268194 | 0.88 | MAPT (0.54) | MAPTCYP1A2SMN1; SMN2NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 339 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119569565-A | Method for synthesizing 2, 5-dihydroxyterephthalic acid | 杭州云上新材有限公司 | 2025-03-07 | — | — | CN | claimed |
| CN-115873227-A | Bio-based high-temperature-resistant polycarbonate and preparation method thereof | 濮阳市盛通聚源新材料有限公司 | 2023-03-31 | — | — | CN | claimed |
| CN-113649055-B | Catalyst for selective hydrogenation of methyl picolinate and preparation method and application thereof | 湖北大学 | 2023-03-24 | — | — | CN | claimed |
| CN-115322350-A | Degradable bio-based polyester and preparation method and application thereof | 苏州瀚海新材料有限公司 | 2022-11-11 | — | — | CN | claimed |
| CN-115246926-A | Poly 2,6-pyridine dicarboxylic acid diol ester based thermoplastic polyester elastomer and preparation method and application thereof | 宁波市医疗中心李惠利医院 | 2022-10-28 | — | — | CN | claimed |
| CN-113649055-A | Catalyst for selective hydrogenation of methyl picolinate and preparation method and application thereof | 湖北大学 | 2021-11-16 | — | — | CN | claimed |
| CN-113461606-A | Pyridine dicarboxylic acid amine derivative as metal beta-lactamase inhibitor and preparation method thereof | 郑州大学 | 2021-10-01 | — | — | CN | claimed |
| WO-2021045088-A1 | METHOD FOR PRODUCING COPOLYESTER, SURFACE MODIFICATION METHOD, AND BONDED OBJECT | 国立大学法人九州大学 | 2021-03-11 | — | — | WO | claimed |
| CN-110818617-A | Preparation method of 2, 6-dichloromethylpyridine hydrochloride | 常州传侑环保科技有限公司 | 2020-02-21 | — | — | CN | claimed |
| CN-109748844-A | A kind of preparation method of 2,6- dichloromethyl pyridine hydrochloride | 丹阳市宁大卫防检测技术有限公司 | 2019-05-14 | — | — | CN | claimed |
| CN-106496110-B | Metallo-β-lactamase inhibitor open chain pyridine carboxylic acid derivatives and preparation method thereof | 郑州大学 | 2019-04-23 | — | — | CN | claimed |
| CN-106496110-A | Metal beta lactamase restrainer open chain pyridine carboxylic acid derivatives and preparation method thereof | 郑州大学 | 2017-03-15 | — | — | CN | claimed |
| US-6176909-B1 | IN POLYMERIC BINDER | XEROX CORPORATION | 2001-01-23 | — | — | US | claimed |
| US-5939568-A | Accelerated catalysis of olefinic epoxidations | THE SCRIPPS RESEARCH INSTITUTE (US) | 1999-08-17 | — | — | US | claimed |
| EP-0598753-B1 | MANGANESE COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS EFFECTIVE AS CATALYSTS FOR DISMUTATING SUPEROXIDE | MONSANTO CO (US) | 1998-03-18 | — | — | EP | claimed |
| US-5610293-A | TREATMENT OF INFLAMMATORY DISEASES, ISCHEMIC/REPERFUSION INJURY, STROKE, ATHERSCLEROSIS, HYPERTENSION | MONSANTO COMPANY (US) | 1997-03-11 | — | — | US | claimed |
| EP-0598753-A1 | MANGANESE COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS EFFECTIVE AS CATALYSTS FOR DISMUTATING SUPEROXIDE | MONSANTO COMPANY (US) | 1994-06-01 | — | — | EP | claimed |
| WO-1993002090-A1 | MANGANESE COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS EFFECTIVE AS CATALYSTS FOR DISMUTATING SUPEROXIDE | MONSANTO COMPANY (US) | 1993-02-04 | — | — | WO | claimed |
| EP-0524161-A1 | Manganese complexes of nitrogen containing macrocyclic ligands effective as catalysts for dismutating superoxide | MONSANTO COMPANY (US) | 1993-01-20 | — | — | EP | claimed |
| CN-122034090-A | Original-flavor cedar fragrance releasing plate and preparation method and application thereof | 北京林业大学 | 2026-05-15 | — | — | CN | disclosed |
| US-20260108482-A1 | MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS | ESCIENT PHARMACEUTICALS INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-12577247-B2 | Diaminopyrazolo[1,5-a]pyrimidine-6-carbonitrile compounds as adenosine 2A receptor and adenosine 2B receptor antagonist | Bugworks Research, Inc. (US) | 2026-03-17 | — | — | US | disclosed |
| WO-2025260150-A1 | NOVEL N-BENZYL PHTHALIMIDES FOR THE TREATMENT OF PAIN. METHODS OF PREPARATION AND THERAPEUTIC USE | MICROBIOLÓGICA QUÍMICA E FARMACÊUTICA LTDA. (BR) | 2025-12-26 | — | — | WO | disclosed |
| WO-2025260159-A1 | ISOINDOLINE AND INDOLINE DERIVATIVE COMPOUNDS, COMBINATIONS, PHARMACEUTICAL COMPOSITIONS, MEDICAMENTS, USE OF THE COMPOUNDS AND METHOD OF TREATMENT OF PAIN | MICROBIOLÓGICA QUÍMICA E FARMACÊUTICA LTDA. (BR) | 2025-12-26 | — | — | WO | disclosed |
| US-20250346561-A1 | TRACERS FOR PETROLEUM RESERVOIRS | SAUDI ARABIAN OIL CO (SA) | 2025-11-13 | — | — | US | disclosed |
| US-12410134-B2 | Tracers for petroleum reservoirs | SAUDI ARABIAN OIL COMPANY (SA) | 2025-09-09 | — | — | US | disclosed |
| US-20250270475-A1 | FABRIC AND HOME CARE COMPOSITION COMPRISING SURFACTANT AND A POLYESTER | THE PROCTER & GAMBLE COMPANY | 2025-08-28 | — | — | US | disclosed |
| US-12384747-B2 | Tracers for petroleum reservoirs | SAUDI ARABIAN OIL COMPANY (SA) | 2025-08-12 | — | — | US | disclosed |
| EP-4569063-A1 | A FABRIC AND HOME CARE COMPOSITION COMPRISING SURFACTANT AND A POLYESTER | The Procter & Gamble Company (US) | 2025-06-18 | — | — | EP | disclosed |
| CN-113939288-B | Modulators of MAS-related G protein receptor X4 and related products and methods | 伊赛恩特制药公司 | 2025-04-25 | — | — | CN | disclosed |
| CN-119569565-A | Method for synthesizing 2, 5-dihydroxyterephthalic acid | 杭州云上新材有限公司 | 2025-03-07 | — | — | CN | disclosed |
| US-20250057990-A1 | TISSUE-SPECIFIC MANGANESE BASED MRI CONTRAST AGENTS | UNIV CASE WESTERN RESERVE (US) | 2025-02-20 | — | — | US | disclosed |
| US-20240308962-A1 | TRACERS FOR PETROLEUM RESERVOIRS | SAUDI ARABIAN OIL COMPANY (SA) | 2024-09-19 | — | — | US | disclosed |
| US-20240300907-A1 | MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS | INCYTE CORPORATION | 2024-09-12 | — | — | US | disclosed |
| US-12077504-B2 | Tracers for petroleum reservoirs | SAUDI ARABIAN OIL COMPANY (SA) | 2024-09-03 | — | — | US | disclosed |
| WO-2024176264-A1 | IONIC LIQUID, ITS FORMULATIONS AND METHOD OF SYNTHESIS THEREOF | PAUL QUDRAT (IN) | 2024-08-29 | — | — | WO | disclosed |
| CN-118439994-A | Preparation method of 2-pyridine carboxamide compound | 江阴迈康升华医药科技有限公司 | 2024-08-06 | — | — | CN | disclosed |
| CN-115322350-B | Degradable bio-based polyester and preparation method and application thereof | 苏州瀚海新材料有限公司 | 2024-04-30 | — | — | CN | disclosed |
| US-20240067606-A1 | TRACERS FOR PETROLEUM RESERVOIRS | SAUDI ARABIAN OIL COMPANY (SA) | 2024-02-29 | — | — | US | disclosed |
| US-20240067606-A1 | TRACERS FOR PETROLEUM RESERVOIRS | SAUDI ARABIAN OIL COMPANY (SA) | 2024-02-29 | — | — | US | disclosed |
| CN-117567457-A | Thiazolone sulfoxide and sulfone compound, and preparation method and application thereof | 华东师范大学 | 2024-02-20 | — | — | CN | disclosed |
| WO-2024036126-A1 | A FABRIC AND HOME CARE COMPOSITION COMPRISING SURFACTANT AND A POLYESTER | THE PROCTER & GAMBLE COMPANY (US) | 2024-02-15 | — | — | WO | disclosed |
| EP-4321604-A1 | A FABRIC AND HOME CARE COMPOSITION COMPRISING SURFACTANT AND A POLYESTER | The Procter & Gamble Company (US) | 2024-02-14 | — | — | EP | disclosed |
| CN-115477606-B | Method for rapidly converting ester into alkyne | 中国科学院兰州化学物理研究所 | 2024-01-26 | — | — | CN | disclosed |
| US-11840521-B2 | Modulators of Mas-related G-protein receptor X4 and related products and methods | ESCIENT PHARMACEUTICALS, INC. (US) | 2023-12-12 | — | — | US | disclosed |
| US-11840521-B2 | Modulators of Mas-related G-protein receptor X4 and related products and methods | ESCIENT PHARMACEUTICALS, INC. (US) | 2023-12-12 | — | — | US | disclosed |
| US-11827604-B2 | Tracers for petroleum reservoirs | SAUDI ARABIAN OIL COMPANY (SA) | 2023-11-28 | — | — | US | disclosed |
| US-11827604-B2 | Tracers for petroleum reservoirs | SAUDI ARABIAN OIL COMPANY (SA) | 2023-11-28 | — | — | US | disclosed |
| US-20230364070-A1 | PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER | ANTARES THERAPEUTICS, INC. | 2023-11-16 | — | — | US | disclosed |
| US-20230364070-A1 | PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER | ANTARES THERAPEUTICS, INC. | 2023-11-16 | — | — | US | disclosed |
| US-20230364070-A1 | PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER | ANTARES THERAPEUTICS, INC. | 2023-11-16 | — | — | US | disclosed |
| EP-3774770-B1 | NOVEL HYDRAZONE DERIVATIVES FOR PREVENTING OR TREATING EBV-RELATED CANCERS | UNIV BRETAGNE OCCIDENTALE (FR) | 2023-09-06 | — | — | EP | disclosed |
| EP-3774770-B1 | NOVEL HYDRAZONE DERIVATIVES FOR PREVENTING OR TREATING EBV-RELATED CANCERS | UNIV BRETAGNE OCCIDENTALE (FR) | 2023-09-06 | — | — | EP | disclosed |
| EP-3318555-B1 | BIFUNCTIONAL CHELATING AGENTS | BWXT MEDICAL LTD (CA) | 2023-08-16 | — | — | EP | disclosed |
| EP-4217070-A1 | PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER | Scorpion Therapeutics, Inc. (US) | 2023-08-02 | — | — | EP | disclosed |
| WO-2023122564-A2 | TISSUE-SPECIFIC MANGANESE BASED MRI CONTRAST AGENTS | CASE WESTERN RESERVE UNIVERSITY (US) | 2023-06-29 | — | — | WO | disclosed |
| US-20230184099-A1 | TRACERS FOR PETROLEUM RESERVOIRS | SAUDI ARABIAN OIL COMPANY (SA) | 2023-06-15 | — | — | US | disclosed |
| US-20230184099-A1 | TRACERS FOR PETROLEUM RESERVOIRS | SAUDI ARABIAN OIL COMPANY (SA) | 2023-06-15 | — | — | US | disclosed |
| US-20230167119-A1 | DIAMINOPYRAZOLO[1,5-A]PYRIMIDINE-6-CARBONITRILE COMPOUNDS AS ADENOSINE 2A RECEPTOR AND ADENOSINE 2B RECEPTOR ANTAGONIST | Bugworks Research, Inc. | 2023-06-01 | — | — | US | disclosed |
| US-20230167119-A1 | DIAMINOPYRAZOLO[1,5-A]PYRIMIDINE-6-CARBONITRILE COMPOUNDS AS ADENOSINE 2A RECEPTOR AND ADENOSINE 2B RECEPTOR ANTAGONIST | Bugworks Research, Inc. | 2023-06-01 | — | — | US | disclosed |
| US-20230167119-A1 | DIAMINOPYRAZOLO[1,5-A]PYRIMIDINE-6-CARBONITRILE COMPOUNDS AS ADENOSINE 2A RECEPTOR AND ADENOSINE 2B RECEPTOR ANTAGONIST | Bugworks Research, Inc. | 2023-06-01 | — | — | US | disclosed |
| US-20230159474-A1 | MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS | INCYTE CORPORATION | 2023-05-25 | — | — | US | disclosed |
| US-20230159474-A1 | MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS | INCYTE CORPORATION | 2023-05-25 | — | — | US | disclosed |
| US-11643399-B2 | Modulators of mas-related G-protein receptor X4 and related products and methods | ESCIENT PHARMACEUTICALS, INC. (US) | 2023-05-09 | — | — | US | disclosed |
| US-11643399-B2 | Modulators of mas-related G-protein receptor X4 and related products and methods | ESCIENT PHARMACEUTICALS, INC. (US) | 2023-05-09 | — | — | US | disclosed |
| CN-115873227-A | Bio-based high-temperature-resistant polycarbonate and preparation method thereof | 濮阳市盛通聚源新材料有限公司 | 2023-03-31 | — | — | CN | disclosed |
| CN-113649055-B | Catalyst for selective hydrogenation of methyl picolinate and preparation method and application thereof | 湖北大学 | 2023-03-24 | — | — | CN | disclosed |
| US-20230053860-A1 | MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS | INCYTE CORPORATION | 2023-02-23 | — | — | US | disclosed |
| US-20230053860-A1 | MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS | INCYTE CORPORATION | 2023-02-23 | — | — | US | disclosed |
| EP-4121431-A1 | DIAMINOPYRAZOLO[1,5-A]PYRIMIDINE-6-CARBONITRILE COMPOUNDS AS ADENOSINE 2A RECEPTOR AND ADENOSINE 2B RECEPTOR ANTAGONIST | Bugworks Research, Inc. (US) | 2023-01-25 | — | — | EP | disclosed |
| CN-111413308-B | Application of rare earth element complex in detection of trace nitrite in mineral water | 延吉海关综合技术服务中心 | 2023-01-20 | — | — | CN | disclosed |
| CN-111320651-B | Chiral amino-pyridine-phosphine tridentate ligand, manganese complex, preparation method and application thereof | 中国科学院上海有机化学研究所 | 2023-01-17 | — | — | CN | disclosed |
| CN-115477606-A | Method for quickly converting ester into alkyne | 中国科学院兰州化学物理研究所 | 2022-12-16 | — | — | CN | disclosed |
| CN-115322350-A | Degradable bio-based polyester and preparation method and application thereof | 苏州瀚海新材料有限公司 | 2022-11-11 | — | — | CN | disclosed |
| CN-115246926-A | Poly 2,6-pyridine dicarboxylic acid diol ester based thermoplastic polyester elastomer and preparation method and application thereof | 宁波市医疗中心李惠利医院 | 2022-10-28 | — | — | CN | disclosed |
| US-11406631-B2 | Hydrazone derivatives for preventing or treating EBV-related cancers | UNIVERSITE DE BRETAGNE OCCIDENTALE | 2022-08-09 | — | — | US | disclosed |
| WO-2022149167-A1 | DIAMINOPYRAZOLO[1,5-A]PYRIMIDINE-6-CARBONITRILE COMPOUNDS AS ADENOSINE 2A RECEPTOR AND ADENOSINE 2B RECEPTOR ANTAGONIST | BUGWORKS RESEARCH INDIA PVT LTD (IN) | 2022-07-14 | — | — | WO | disclosed |
| WO-2022149167-A1 | DIAMINOPYRAZOLO[1,5-A]PYRIMIDINE-6-CARBONITRILE COMPOUNDS AS ADENOSINE 2A RECEPTOR AND ADENOSINE 2B RECEPTOR ANTAGONIST | BUGWORKS RESEARCH INDIA PVT LTD (IN) | 2022-07-14 | — | — | WO | disclosed |
| US-20220170363-A1 | TRACERS FOR PETROLEUM RESERVOIRS | SAUDI ARABIAN OIL COMPANY (SA) | 2022-06-02 | — | — | US | disclosed |
| US-20220170363-A1 | TRACERS FOR PETROLEUM RESERVOIRS | SAUDI ARABIAN OIL COMPANY (SA) | 2022-06-02 | — | — | US | disclosed |
| US-20220170362-A1 | TRACERS FOR PETROLEUM RESERVOIRS | SAUDI ARABIAN OIL COMPANY (SA) | 2022-06-02 | — | — | US | disclosed |
| US-20220170362-A1 | TRACERS FOR PETROLEUM RESERVOIRS | SAUDI ARABIAN OIL COMPANY (SA) | 2022-06-02 | — | — | US | disclosed |
| CN-113461606-B | Pyridine dicarboxylic acid amine derivative as metal beta-lactamase inhibitor and preparation method thereof | 郑州大学 | 2022-05-31 | — | — | CN | disclosed |
| US-20220160908-A1 | CHELATORS AND METHODS OF MAKING AND USING SAME | PROVINCIAL HEALTH SERVICES AUTHORITY (CA) | 2022-05-26 | — | — | US | disclosed |
| US-20220160908-A1 | CHELATORS AND METHODS OF MAKING AND USING SAME | PROVINCIAL HEALTH SERVICES AUTHORITY (CA) | 2022-05-26 | — | — | US | disclosed |
| US-20220125944-A1 | ANTIBODY-DRUG CONJUGATE AND USE THEREOF | ABL BIO, INC. (KR) | 2022-04-28 | — | — | US | disclosed |
| US-11299982-B2 | Tracers for petroleum reservoirs | SAUDI ARABIAN OIL COMPANY (SA) | 2022-04-12 | — | — | US | disclosed |
| WO-2022066734-A1 | PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER | SCORPION THERAPEUTICS, INC. (US) | 2022-03-31 | — | — | WO | disclosed |
| EP-3946304-A1 | MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS | ESCIENT PHARMACEUTICALS, INC. (US) | 2022-02-09 | — | — | EP | disclosed |
| US-11230919-B2 | Tracers for petroleum reservoirs | SAUDI ARABIAN OIL COMPANY (SA) | 2022-01-25 | — | — | US | disclosed |
| US-11230919-B2 | Tracers for petroleum reservoirs | SAUDI ARABIAN OIL COMPANY (SA) | 2022-01-25 | — | — | US | disclosed |
| CN-113939288-A | Modulators of MAS-related G protein receptor X4 and related products and methods | 伊赛恩特制药公司 | 2022-01-14 | — | — | CN | disclosed |
| EP-3936151-A1 | ANTIBODY-DRUG CONJUGATE AND USE THEREOF | ABL Bio, Inc. (KR) | 2022-01-12 | — | — | EP | disclosed |
| CN-113649055-A | Catalyst for selective hydrogenation of methyl picolinate and preparation method and application thereof | 湖北大学 | 2021-11-16 | — | — | CN | disclosed |
| CN-113461606-A | Pyridine dicarboxylic acid amine derivative as metal beta-lactamase inhibitor and preparation method thereof | 郑州大学 | 2021-10-01 | — | — | CN | disclosed |
| CN-111925512-B | Photochromic polyester and preparation method and application thereof | 中国科学院宁波材料技术与工程研究所 | 2021-08-06 | — | — | CN | disclosed |
| WO-2021121294-A1 | TRIAZOLOPYRIDAZINE DERIVATIVE, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF | 上海赛默罗生物科技有限公司 | 2021-06-24 | — | — | WO | disclosed |
| WO-2021123013-A1 | SMART DRUG DELIVERY SYSTEM AND PHARMACEUTICAL KIT FOR DUAL NUCLEAR MEDICAL CYTOTOXIC THERANOSTICS | Johannes Gutenberg-Universität Mainz (DE) | 2021-06-24 | — | — | WO | disclosed |
| US-20210161887-A1 | Novel Hydrazone Derivatives For Preventing Or Treating EBV-Related Cancers | UNIVERSITE DE BRETAGNE OCCIDENTALE (FR) | 2021-06-03 | — | — | US | disclosed |
| US-20210161887-A1 | Novel Hydrazone Derivatives For Preventing Or Treating EBV-Related Cancers | UNIVERSITE DE BRETAGNE OCCIDENTALE (FR) | 2021-06-03 | — | — | US | disclosed |
| CN-108026126-B | Dehydrosilylation, hydrosilylation, and crosslinking using pyridine diimine cobalt carboxylate catalysts | 莫门蒂夫性能材料股份有限公司 | 2021-04-20 | — | — | CN | disclosed |
| CN-108864428-B | Boron-containing silicone oil with heat-resistant and aging-resistant main chain belt pyridine structure and preparation method thereof | 合肥工业大学 | 2021-04-06 | — | — | CN | disclosed |
| WO-2021045088-A1 | METHOD FOR PRODUCING COPOLYESTER, SURFACE MODIFICATION METHOD, AND BONDED OBJECT | 国立大学法人九州大学 | 2021-03-11 | — | — | WO | disclosed |
| WO-2021045088-A1 | METHOD FOR PRODUCING COPOLYESTER, SURFACE MODIFICATION METHOD, AND BONDED OBJECT | 国立大学法人九州大学 | 2021-03-11 | — | — | WO | disclosed |
| EP-3774770-A1 | NOVEL HYDRAZONE DERIVATIVES FOR PREVENTING OR TREATING EBV-RELATED CANCERS | Université de Bretagne Occidentale (FR) | 2021-02-17 | — | — | EP | disclosed |
| US-20210032213-A1 | MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS | INCYTE CORPORATION | 2021-02-04 | — | — | US | disclosed |
| US-20210032213-A1 | MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS | INCYTE CORPORATION | 2021-02-04 | — | — | US | disclosed |
| US-10858383-B2 | Remote heteroaryl alkenylation with catalytic bifunctional template | THE SCRIPPS RESEARCH INSTITUTE (US) | 2020-12-08 | — | — | US | disclosed |
| EP-3740544-A2 | TRACERS FOR PETROLEUM RESERVOIRS | Saudi Arabian Oil Company (SA) | 2020-11-25 | — | — | EP | disclosed |
| CN-111925512-A | Photochromic polyester and preparation method and application thereof | 中国科学院宁波材料技术与工程研究所 | 2020-11-13 | — | — | CN | disclosed |
| US-10822326-B2 | Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2020-11-03 | — | — | US | disclosed |
| US-10822326-B2 | Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2020-11-03 | — | — | US | disclosed |
| WO-2020198537-A1 | MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS | ESCIENT PHARMACEUTICALS, INC. (US) | 2020-10-01 | — | — | WO | disclosed |
| WO-2020198537-A1 | MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS | ESCIENT PHARMACEUTICALS, INC. (US) | 2020-10-01 | — | — | WO | disclosed |
| WO-2020186328-A1 | CHELATORS AND METHODS OF MAKING AND USING SAME | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2020-09-24 | — | — | WO | disclosed |
| WO-2020186328-A1 | CHELATORS AND METHODS OF MAKING AND USING SAME | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2020-09-24 | — | — | WO | disclosed |
| US-10717752-B2 | Dehydrogenative silylation, hydrosilylation and crosslinking using pyridinediimine cobalt carboxylate catalysts | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2020-07-21 | — | — | US | disclosed |
| US-10717752-B2 | Dehydrogenative silylation, hydrosilylation and crosslinking using pyridinediimine cobalt carboxylate catalysts | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2020-07-21 | — | — | US | disclosed |
| CN-111413308-A | Application of rare earth element complex in detection of trace nitrite in mineral water | 延吉海关综合技术服务中心 | 2020-07-14 | — | — | CN | disclosed |
| US-10696694-B2 | Lanthanide complexes for crystallising biological macromolecules and determining the crystallographic structure thereof | ECOLE NORMALE SUPERIEURE LE LYON (FR) | 2020-06-30 | — | — | US | disclosed |
| CN-111320651-A | Chiral amino-pyridine-phosphine tridentate ligand, manganese complex, preparation method and application thereof | 中国科学院上海有机化学研究所 | 2020-06-23 | — | — | CN | disclosed |
| US-20200190058-A1 | SUBSTITUTED HETEROARYL ALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION | GLOBAL BLOOD THERAPEUTICS, INC. | 2020-06-18 | — | — | US | disclosed |
| US-20200190058-A1 | SUBSTITUTED HETEROARYL ALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION | GLOBAL BLOOD THERAPEUTICS, INC. | 2020-06-18 | — | — | US | disclosed |
| US-20200155689-A1 | CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME | ARVINAS OPERATIONS, INC. | 2020-05-21 | — | — | US | disclosed |
| US-10654825-B2 | Processes for making triazolo[4,5D] pyramidine derivatives and intermediates thereof | CORVUS PHARMACEUTICALS, INC. (US) | 2020-05-19 | — | — | US | disclosed |
| US-10654825-B2 | Processes for making triazolo[4,5D] pyramidine derivatives and intermediates thereof | CORVUS PHARMACEUTICALS, INC. (US) | 2020-05-19 | — | — | US | disclosed |
| US-20200131213-A1 | Remote Heteroaryl Alkenylation With Catalytic Bifunctional Template | THE SCRIPPS RESEARCH INSTITUTE | 2020-04-30 | — | — | US | disclosed |
| EP-2797597-B1 | SUBSTITUTED HETEROARYL ALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION | GLOBAL BLOOD THERAPEUTICS INC (US) | 2020-02-26 | — | — | EP | disclosed |
| EP-2797597-B1 | SUBSTITUTED HETEROARYL ALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION | GLOBAL BLOOD THERAPEUTICS INC (US) | 2020-02-26 | — | — | EP | disclosed |
| CN-110818617-A | Preparation method of 2, 6-dichloromethylpyridine hydrochloride | 常州传侑环保科技有限公司 | 2020-02-21 | — | — | CN | disclosed |
| CN-110818617-A | Preparation method of 2, 6-dichloromethylpyridine hydrochloride | 常州传侑环保科技有限公司 | 2020-02-21 | — | — | CN | disclosed |
| WO-2020035593-A1 | COPOLYMER BLENDS | BIOME BIOPLASTICS LIMITED (GB) | 2020-02-20 | — | — | WO | disclosed |
| EP-3600292-A1 | PROCESSES FOR MAKING TRIAZOLO[4,5D]PYRAMIDINE DERIVATIVES AND INTERMEDIATES THEREOF | Corvus Pharmaceuticals, Inc. (US) | 2020-02-05 | — | — | EP | disclosed |
| WO-2019199816-A1 | CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME | ARVINAS OPERATIONS, INC. (US) | 2019-10-17 | — | — | WO | disclosed |
| WO-2019193071-A1 | NOVEL HYDRAZONE DERIVATIVES FOR PREVENTING OR TREATING EBV-RELATED CANCERS | UNIVERSITE DE BRETAGNE OCCIDENTALE (FR) | 2019-10-10 | — | — | WO | disclosed |
| WO-2019193071-A1 | NOVEL HYDRAZONE DERIVATIVES FOR PREVENTING OR TREATING EBV-RELATED CANCERS | UNIVERSITE DE BRETAGNE OCCIDENTALE (FR) | 2019-10-10 | — | — | WO | disclosed |
| EP-3549938-A1 | NOVEL HYDRAZONE DERIVATIVES FOR PREVENTING OR TREATING EBV-RELATED CANCERS | Université de Bretagne Occidentale (FR) | 2019-10-09 | — | — | EP | disclosed |
| EP-3549938-A1 | NOVEL HYDRAZONE DERIVATIVES FOR PREVENTING OR TREATING EBV-RELATED CANCERS | Université de Bretagne Occidentale (FR) | 2019-10-09 | — | — | EP | disclosed |
| US-10435528-B2 | High-capacity anion exchange materials | AQUANANO LLC (US) | 2019-10-08 | — | — | US | disclosed |
| EP-3325492-B1 | DEHYDROGENATIVE SILYLATION, HYDROSILYLATION AND CROSSLINKING USING PYRIDINEDIIMINE COBALT CARBOXYLATE CATALYSTS | MOMENTIVE PERFORMANCE MAT INC (US) | 2019-09-18 | — | — | EP | disclosed |
| EP-3325492-B1 | DEHYDROGENATIVE SILYLATION, HYDROSILYLATION AND CROSSLINKING USING PYRIDINEDIIMINE COBALT CARBOXYLATE CATALYSTS | MOMENTIVE PERFORMANCE MAT INC (US) | 2019-09-18 | — | — | EP | disclosed |
| US-10377741-B2 | Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2019-08-13 | — | — | US | disclosed |
| US-10377741-B2 | Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2019-08-13 | — | — | US | disclosed |
| US-20190226326-A1 | TRACERS FOR PETROLEUM RESERVOIRS | SAUDI ARABIAN OIL COMPANY (SA) | 2019-07-25 | — | — | US | disclosed |
| WO-2019143917-A2 | TRACERS FOR PETROLEUM RESERVOIRS | SAUDI ARABIAN OIL COMPANY (SA) | 2019-07-25 | — | — | WO | disclosed |
| US-20190226326-A1 | TRACERS FOR PETROLEUM RESERVOIRS | SAUDI ARABIAN OIL COMPANY (SA) | 2019-07-25 | — | — | US | disclosed |
| WO-2019143917-A2 | TRACERS FOR PETROLEUM RESERVOIRS | SAUDI ARABIAN OIL COMPANY (SA) | 2019-07-25 | — | — | WO | disclosed |
| US-20190218907-A1 | TRACERS FOR PETROLEUM RESERVOIRS | SAUDI ARABIAN OIL COMPANY (SA) | 2019-07-18 | — | — | US | disclosed |
| US-20190218907-A1 | TRACERS FOR PETROLEUM RESERVOIRS | SAUDI ARABIAN OIL COMPANY (SA) | 2019-07-18 | — | — | US | disclosed |
| CN-109748844-A | A kind of preparation method of 2,6- dichloromethyl pyridine hydrochloride | 丹阳市宁大卫防检测技术有限公司 | 2019-05-14 | — | — | CN | disclosed |
| CN-109748844-A | A kind of preparation method of 2,6- dichloromethyl pyridine hydrochloride | 丹阳市宁大卫防检测技术有限公司 | 2019-05-14 | — | — | CN | disclosed |
| CN-106496110-B | Metallo-β-lactamase inhibitor open chain pyridine carboxylic acid derivatives and preparation method thereof | 郑州大学 | 2019-04-23 | — | — | CN | disclosed |
| US-20180354929-A1 | SUBSTITUTED HETEROARYL ALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION | GLOBAL BLOOD THERAPEUTICS, INC. | 2018-12-13 | — | — | US | disclosed |
| US-20180290999-A1 | PROCESSES FOR MAKING TRIAZOLO[4,5D] PYRAMIDINE DERIVATIVES AND INTERMEDIATES THEREOF | CORVUS PHARMACEUTICALS, INC. | 2018-10-11 | — | — | US | disclosed |
| WO-2018183965-A1 | PROCESSES FOR MAKING TRIAZOLO[4,5D] PYRAMIDINE DERIVATIVES AND INTERMEDIATES THEREOF | CORVUS PHARMACEUTICALS, INC. (GB) | 2018-10-04 | — | — | WO | disclosed |
| US-20180201634-A1 | DEHYDROGENATIVE SILYLATION, HYDROSILYLATION AND CROSSLINKING USING PYRIDINEDIIMINE COBALT CARBOXYLATE CATALYSTS | MOMENTIVE PERFORMANCE MATERIALS INC. | 2018-07-19 | — | — | US | disclosed |
| US-20180201634-A1 | DEHYDROGENATIVE SILYLATION, HYDROSILYLATION AND CROSSLINKING USING PYRIDINEDIIMINE COBALT CARBOXYLATE CATALYSTS | MOMENTIVE PERFORMANCE MATERIALS INC. | 2018-07-19 | — | — | US | disclosed |
| EP-3325492-A1 | DEHYDROGENATIVE SILYLATION, HYDROSILYLATION AND CROSSLINKING USING PYRIDINEDIIMINE COBALT CARBOXYLATE CATALYSTS | Momentive Performance Materials Inc. (US) | 2018-05-30 | — | — | EP | disclosed |
| EP-3318555-A1 | BIFUNCTIONAL CHELATING AGENTS | Nordion (Canada) Inc. (CA) | 2018-05-09 | — | — | EP | disclosed |
| US-9845310-B2 | Intermediates for preparing triazole agonists of the APJ receptor | AMGEN INC. (US) | 2017-12-19 | — | — | US | disclosed |
| EP-2536691-B1 | BIFUNCTIONAL CHELATING AGENTS | Nordion (Canada) Inc (CA) | 2017-11-22 | — | — | EP | disclosed |
| EP-2536691-B1 | BIFUNCTIONAL CHELATING AGENTS | Nordion (Canada) Inc (CA) | 2017-11-22 | — | — | EP | disclosed |
| US-9823534-B2 | Electrochromic single and two-core viologens and optical articles containing them | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2017-11-21 | — | — | US | disclosed |
| US-9826129-B2 | Near-infrared-ray-absorbing composition, near-infrared-ray cut filter using same, manufacturing method therefor, camera module, and manufacturing method therefor | FUJIFILM CORPORATION (JP) | 2017-11-21 | — | — | US | disclosed |
| EP-3077385-B1 | HETEROARYL DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASES | CHIESI FARM SPA (IT) | 2017-10-04 | — | — | EP | disclosed |
| US-20170240485-A1 | Synthesis of Esters by Functionalisation of CO2 | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2017-08-24 | — | — | US | disclosed |
| WO-2017103545-A1 | LANTHANIDE COMPLEXES FOR CRYSTALLISING BIOLOGICAL MACROMOLECULES AND DETERMINING THE CRYSTALLOGRAPHIC STRUCTURE THEREOF | ECOLE NORMALE SUPERIEURE DE LYON (FR) | 2017-06-22 | — | — | WO | disclosed |
| US-20170107199-A1 | SUBSTITUTED HETEROARYL ALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION | GLOBAL BLOOD THERAPEUTICS INC (US) | 2017-04-20 | — | — | US | disclosed |
| US-20170107199-A1 | SUBSTITUTED HETEROARYL ALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION | GLOBAL BLOOD THERAPEUTICS INC (US) | 2017-04-20 | — | — | US | disclosed |
| US-20170107199-A1 | SUBSTITUTED HETEROARYL ALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION | GLOBAL BLOOD THERAPEUTICS INC (US) | 2017-04-20 | — | — | US | disclosed |
| CN-106496110-A | Metal beta lactamase restrainer open chain pyridine carboxylic acid derivatives and preparation method thereof | 郑州大学 | 2017-03-15 | — | — | CN | disclosed |
| US-20170035744-A1 | TRIAZOLE AGONISTS OF THE APJ RECEPTOR | AMGEN INC. | 2017-02-09 | — | — | US | disclosed |
| WO-2017019473-A1 | DEHYDROGENATIVE SILYLATION, HYDROSILYLATION AND CROSSLINKING USING PYRIDINEDIIMINE COBALT CARBOXYLATE CATALYSTS | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2017-02-02 | — | — | WO | disclosed |
| WO-2017019473-A1 | DEHYDROGENATIVE SILYLATION, HYDROSILYLATION AND CROSSLINKING USING PYRIDINEDIIMINE COBALT CARBOXYLATE CATALYSTS | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2017-02-02 | — | — | WO | disclosed |
| EP-3077385-A1 | HETEROARYL DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASES | Chiesi Farmaceutici S.p.A. (IT) | 2016-10-12 | — | — | EP | disclosed |
| US-20160231635-A1 | ELECTROCHROMIC SINGLE AND TWO-CORE VIOLOGENS AND OPTICAL ARTICLES CONTAINING THEM | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2016-08-11 | — | — | US | disclosed |
| CN-105793250-A | Heteroaryl derivatives for the treatment of respiratory diseases | 奇斯药制品公司 | 2016-07-20 | — | — | CN | disclosed |
| WO-2016043808-A1 | HIGH-CAPACITY ANION EXCHANGE MATERIAL | AQUANANO LLC (US) | 2016-03-24 | — | — | WO | disclosed |
| US-20160037034-A1 | NEAR-INFRARED-RAY-ABSORBING COMPOSITION, NEAR-INFRARED-RAY CUT FILTER USING SAME, MANUFACTURING METHOD THEREFOR, CAMERA MODULE, AND MANUFACTURING METHOD THEREFOR | FUJIFILM CORPORATION (JP) | 2016-02-04 | — | — | US | disclosed |
| US-20150344483-A1 | SUBSTITUTED HETEROARYL ALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION | GLOBAL BLOOD THERAPEUTICS, INC. | 2015-12-03 | — | — | US | disclosed |
| US-20150344483-A1 | SUBSTITUTED HETEROARYL ALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION | GLOBAL BLOOD THERAPEUTICS, INC. | 2015-12-03 | — | — | US | disclosed |
| US-20150344483-A1 | SUBSTITUTED HETEROARYL ALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION | GLOBAL BLOOD THERAPEUTICS, INC. | 2015-12-03 | — | — | US | disclosed |
| US-20150291538-A1 | Macrocyclic Compositions And Metal Complexes For Bioimaging And Biomedical Applications | UNIV NAT YANG MING (TW) | 2015-10-15 | — | — | US | disclosed |
| EP-2511260-B1 | AROMATIC COMPOUND, MODIFICATION CARRIER THAT USES SAME AND IS USED FOR SYNTHESIZING AN OLIGONUCLEOTIDE DERIVATIVE, OLIGONUCLEOTIDE DERIVATIVE, AND OLIGONUCLEOTIDE CONSTRUCT | UNIV GIFU (JP) | 2015-07-29 | — | — | EP | disclosed |
| EP-2511260-B1 | AROMATIC COMPOUND, MODIFICATION CARRIER THAT USES SAME AND IS USED FOR SYNTHESIZING AN OLIGONUCLEOTIDE DERIVATIVE, OLIGONUCLEOTIDE DERIVATIVE, AND OLIGONUCLEOTIDE CONSTRUCT | UNIV GIFU (JP) | 2015-07-29 | — | — | EP | disclosed |
| CN-103396789-B | Triphenylamine two-photon fluorescence probe compound and preparation method and application thereof | UNIV SHANGHAI | 2015-07-01 | — | — | CN | disclosed |
| US-9062009-B2 | Macrocyclic compounds and metal complexes for bioimaging and biomedical applications | NATIONAL YANG MING UNIVERSITY (TW) | 2015-06-23 | — | — | US | disclosed |
| WO-2015082616-A1 | HETEROARYL DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASES | CHIESI FARMACEUTICI S.P.A. (IT) | 2015-06-11 | — | — | WO | disclosed |
| US-9012450-B2 | Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2015-04-21 | — | — | US | disclosed |
| US-9012450-B2 | Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2015-04-21 | — | — | US | disclosed |
| WO-2015040033-A2 | ELECTROCHROMIC SINGLE AND TWO-CORE VIOLOGENS AND OPTICAL ARTICLES CONTAINING THEM | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2015-03-26 | — | — | WO | disclosed |
| US-20150076072-A1 | HIGH-CAPACITY ANION EXCHANGE MATERIALS | AQUANANO LLC | 2015-03-19 | — | — | US | disclosed |
| CN-103339269-B | Process for separating americium from other metallic elements present in an acidic aqueous or organic phase and applications thereof | COMMISSARIAT ENERGIE ATOMIQUE | 2015-02-25 | — | — | CN | disclosed |
| EP-2797597-A1 | SUBSTITUTED HETEROARYL ALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION | Global Blood Therapeutics, Inc. (US) | 2014-11-05 | — | — | EP | disclosed |
| US-8853237-B2 | Naphthyridinone analogs as mGluR5 positive allosteric modulators | VANDERBILT UNIVERSITY (US) | 2014-10-07 | — | — | US | disclosed |
| US-8853237-B2 | Naphthyridinone analogs as mGluR5 positive allosteric modulators | VANDERBILT UNIVERSITY (US) | 2014-10-07 | — | — | US | disclosed |
| US-20140194349-A1 | HIV Protease Inhibiting Compounds | ABBVIE INC. (US) | 2014-07-10 | — | — | US | disclosed |
| US-8772446-B2 | Bifunctional chelating agents | NORDION (CANADA) INC. (CA) | 2014-07-08 | — | — | US | disclosed |
| US-8772446-B2 | Bifunctional chelating agents | NORDION (CANADA) INC. (CA) | 2014-07-08 | — | — | US | disclosed |
| US-8772446-B2 | Bifunctional chelating agents | NORDION (CANADA) INC. (CA) | 2014-07-08 | — | — | US | disclosed |
| US-20140187527-A1 | Macrocyclic Compounds And Metal Complexes For Bioimaging And Biomedical Applications | NATIONAL YANG MING UNIVERSITY (TW) | 2014-07-03 | — | — | US | disclosed |
| US-8710074-B2 | Dihydronaphthyridinyl(organo)methanone analogs as positive allosteric mGluR5 modulators | VANDERBILT UNIVERSITY (US) | 2014-04-29 | — | — | US | disclosed |
| US-8633304-B2 | Oligonucleotide derivative comprising an aromatic compound | GIFU UNIVERSITY (JP) | 2014-01-21 | — | — | US | disclosed |
| US-8633304-B2 | Oligonucleotide derivative comprising an aromatic compound | GIFU UNIVERSITY (JP) | 2014-01-21 | — | — | US | disclosed |
| US-8633304-B2 | Oligonucleotide derivative comprising an aromatic compound | GIFU UNIVERSITY (JP) | 2014-01-21 | — | — | US | disclosed |
| CN-103339269-A | Process for separating americium from other metallic elements present in an acidic aqueous or organic phase and applications thereof | COMMISSARIAT ENERGIE ATOMIQUE | 2013-10-02 | — | — | CN | disclosed |
| US-20130190316-A1 | SUBSTITUTED HETEROARYL ALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2013-07-25 | — | — | US | disclosed |
| US-20130190316-A1 | SUBSTITUTED HETEROARYL ALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2013-07-25 | — | — | US | disclosed |
| WO-2013102145-A1 | SUBSTITUTED HETEROARYL ALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2013-07-04 | — | — | WO | disclosed |
| WO-2013102145-A1 | SUBSTITUTED HETEROARYL ALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2013-07-04 | — | — | WO | disclosed |
| EP-2536691-A1 | BIFUNCTIONAL CHELATING AGENTS | Nordion (Canada) Inc. (CA) | 2012-12-26 | — | — | EP | disclosed |
| EP-2511260-A1 | AROMATIC COMPOUND, MODIFICATION CARRIER THAT USES SAME AND IS USED FOR SYNTHESIZING AN OLIGONUCLEOTIDE DERIVATIVE, OLIGONUCLEOTIDE DERIVATIVE, AND OLIGONUCLEOTIDE CONSTRUCT | Gifu University (JP) | 2012-10-17 | — | — | EP | disclosed |
| EP-2511260-A1 | AROMATIC COMPOUND, MODIFICATION CARRIER THAT USES SAME AND IS USED FOR SYNTHESIZING AN OLIGONUCLEOTIDE DERIVATIVE, OLIGONUCLEOTIDE DERIVATIVE, AND OLIGONUCLEOTIDE CONSTRUCT | Gifu University (JP) | 2012-10-17 | — | — | EP | disclosed |
| US-20120245341-A1 | AROMATIC COMPOUND, MODIFICATION CARRIER THAT USES SAME AND IS USED FOR SYNTHESIZING AN OLIGONUCLEOTIDE DERIVATIVE, OLIGONUCLEOTIDE DERIVATIVE, AND OLIGONUCLEOTIDE CONSTRUCT | GIFU UNIVERSITY (JP) | 2012-09-27 | — | — | US | disclosed |
| US-20120245341-A1 | AROMATIC COMPOUND, MODIFICATION CARRIER THAT USES SAME AND IS USED FOR SYNTHESIZING AN OLIGONUCLEOTIDE DERIVATIVE, OLIGONUCLEOTIDE DERIVATIVE, AND OLIGONUCLEOTIDE CONSTRUCT | GIFU UNIVERSITY (JP) | 2012-09-27 | — | — | US | disclosed |
| US-20120245341-A1 | AROMATIC COMPOUND, MODIFICATION CARRIER THAT USES SAME AND IS USED FOR SYNTHESIZING AN OLIGONUCLEOTIDE DERIVATIVE, OLIGONUCLEOTIDE DERIVATIVE, AND OLIGONUCLEOTIDE CONSTRUCT | GIFU UNIVERSITY (JP) | 2012-09-27 | — | — | US | disclosed |
| EP-2479203-A1 | AROMATIC POLYESTER | Muroran Institute of Technology (JP) | 2012-07-25 | — | — | EP | disclosed |
| WO-2012097182-A1 | DIHYDRONAPHTHYRIDINYL(ORGANO)METHANONE ANALOGS AS POSITIVE ALLOSTERIC MGLUR5 MODULATORS | VANDERBILT UNIVERSITY (US) | 2012-07-19 | — | — | WO | disclosed |
| WO-2012097182-A1 | DIHYDRONAPHTHYRIDINYL(ORGANO)METHANONE ANALOGS AS POSITIVE ALLOSTERIC MGLUR5 MODULATORS | VANDERBILT UNIVERSITY (US) | 2012-07-19 | — | — | WO | disclosed |
| US-20120178776-A1 | DIHYDRONAPHTHYRIDINYL(ORGANO)METHANONE ANALOGS AS POSITIVE ALLOSTERIC MGLUR5 MODULATORS | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2012-07-12 | — | — | US | disclosed |
| US-20120178776-A1 | DIHYDRONAPHTHYRIDINYL(ORGANO)METHANONE ANALOGS AS POSITIVE ALLOSTERIC MGLUR5 MODULATORS | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2012-07-12 | — | — | US | disclosed |
| US-20120178776-A1 | DIHYDRONAPHTHYRIDINYL(ORGANO)METHANONE ANALOGS AS POSITIVE ALLOSTERIC MGLUR5 MODULATORS | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2012-07-12 | — | — | US | disclosed |
| US-20120172570-A1 | AROMATIC POLYESTER | NITTA CORPORATION | 2012-07-05 | — | — | US | disclosed |
| US-20120172391-A1 | NAPHTHYRIDINONE ANALOGS AS MGLUR5 POSITIVE ALLOSTERIC MODULATORS | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2012-07-05 | — | — | US | disclosed |
| US-20120172391-A1 | NAPHTHYRIDINONE ANALOGS AS MGLUR5 POSITIVE ALLOSTERIC MODULATORS | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2012-07-05 | — | — | US | disclosed |
| US-20120088918-A1 | Continuous Method For Producing Esters Of Aromatic Carboxylic Acids | CLARIANT FINANCE (BVI) LIMITED (VG) | 2012-04-12 | — | — | US | disclosed |
| US-8129493-B2 | Aromatic polyester | MURORAN INSTITUTE OF TECHNOLOGY (JP) | 2012-03-06 | — | — | US | disclosed |
| US-8084449-B2 | Dual pharmacophores—PDE4-muscarinic antagonistics | GLAXO GROUP LIMITED (GB) | 2011-12-27 | — | — | US | disclosed |
| US-8084449-B2 | Dual pharmacophores—PDE4-muscarinic antagonistics | GLAXO GROUP LIMITED (GB) | 2011-12-27 | — | — | US | disclosed |
| US-8084449-B2 | Dual pharmacophores—PDE4-muscarinic antagonistics | GLAXO GROUP LIMITED (GB) | 2011-12-27 | — | — | US | disclosed |
| US-20110313130-A1 | BIFUNCTIONAL CHELATING AGENTS | NORDION (CANADA) INC. | 2011-12-22 | — | — | US | disclosed |
| US-20110313130-A1 | BIFUNCTIONAL CHELATING AGENTS | NORDION (CANADA) INC. | 2011-12-22 | — | — | US | disclosed |
| US-20110313130-A1 | BIFUNCTIONAL CHELATING AGENTS | NORDION (CANADA) INC. | 2011-12-22 | — | — | US | disclosed |
| EP-1697344-B1 | HIV PROTEASE INHIBITING COMPOUNDS | ABBOTT LAB (US) | 2011-09-28 | — | — | EP | disclosed |
| US-20110224343-A1 | MODIFIER FOR AROMATIC POLYESTER AND AROMATIC POLYESTER RESIN COMPOSITION COMPRISING THE SAME | MURORAN INSTITUTE OF TECHNOLOGY (JP) | 2011-09-15 | — | — | US | disclosed |
| WO-2011100829-A1 | BIFUNCTIONAL CHELATING AGENTS | NORDION (CANADA) INC. (CA) | 2011-08-25 | — | — | WO | disclosed |
| WO-2011100829-A1 | BIFUNCTIONAL CHELATING AGENTS | NORDION (CANADA) INC. (CA) | 2011-08-25 | — | — | WO | disclosed |
| WO-2011071078-A1 | AROMATIC COMPOUND, MODIFICATION CARRIER THAT USES SAME AND IS USED FOR SYNTHESIZING AN OLIGONUCLEOTIDE DERIVATIVE, OLIGONUCLEOTIDE DERIVATIVE, AND OLIGONUCLEOTIDE CONSTRUCT | 国立大学法人岐阜大学 (JP) | 2011-06-16 | — | — | WO | disclosed |
| US-20110092662-A1 | AROMATIC POLYESTER | NITTA CORPORATION (JP) | 2011-04-21 | — | — | US | disclosed |
| CN-101990401-A | Dual pharmacophores-PDE 4-muscarinic antagonists | GLAXO GROUP LTD | 2011-03-23 | — | — | CN | disclosed |
| EP-2266971-A2 | Hiv protease inhibiting compounds | Abbott Laboratories (US) | 2010-12-29 | — | — | EP | disclosed |
| EP-2259681-A1 | DUAL PHARMACOPHORES-PDE4-MUSCARINIC ANTAGONISTICS | Glaxo Group Limited (GB) | 2010-12-15 | — | — | EP | disclosed |
| US-7834043-B2 | Prevent reproduct of aids virus | ABBOTT LABORATORIES (US) | 2010-11-16 | — | — | US | disclosed |
| US-20100249181-A1 | HIV Protease Inhibiting Compounds | ABBOTT LABORATORIES (US) | 2010-09-30 | — | — | US | disclosed |
| US-7696210-B2 | Gonadotropin releasing hormone receptor antagonists | WYETH (US) | 2010-04-13 | — | — | US | disclosed |
| US-7696210-B2 | Gonadotropin releasing hormone receptor antagonists | WYETH (US) | 2010-04-13 | — | — | US | disclosed |
| US-20090203657-A1 | Dual Pharmacophores - PDE4-Muscarinic Antagonistics | GLAXO GROUP LIMITED (GB) | 2009-08-13 | — | — | US | disclosed |
| US-20090203657-A1 | Dual Pharmacophores - PDE4-Muscarinic Antagonistics | GLAXO GROUP LIMITED (GB) | 2009-08-13 | — | — | US | disclosed |
| US-20090203657-A1 | Dual Pharmacophores - PDE4-Muscarinic Antagonistics | GLAXO GROUP LIMITED (GB) | 2009-08-13 | — | — | US | disclosed |
| WO-2009100166-A1 | DUAL PHARMACOPHORES-PDE4-MUSCARINIC ANTAGONISTICS | GLAXO GROUP LIMITED (GB) | 2009-08-13 | — | — | WO | disclosed |
| WO-2009100166-A1 | DUAL PHARMACOPHORES-PDE4-MUSCARINIC ANTAGONISTICS | GLAXO GROUP LIMITED (GB) | 2009-08-13 | — | — | WO | disclosed |
| US-20090098047-A1 | BIOCONJUGATES OF METAL COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS | INOTEK PHARMACEUTICALS (NZ) | 2009-04-16 | — | — | US | disclosed |
| US-20090098047-A1 | BIOCONJUGATES OF METAL COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS | INOTEK PHARMACEUTICALS (NZ) | 2009-04-16 | — | — | US | disclosed |
| US-20090023717-A1 | MORPHINE-BRIDGED INDAZOLE DERIVATIVES | FEURER ACHIM | 2009-01-22 | — | — | US | disclosed |
| US-20090023717-A1 | MORPHINE-BRIDGED INDAZOLE DERIVATIVES | FEURER ACHIM | 2009-01-22 | — | — | US | disclosed |
| US-20080312240-A1 | Bicyclic Piperazines as Metabotropic Glutatmate Receptor Antagonists | ASTRAZENECA AB (SE) | 2008-12-18 | — | — | US | disclosed |
| US-20080312240-A1 | Bicyclic Piperazines as Metabotropic Glutatmate Receptor Antagonists | ASTRAZENECA AB (SE) | 2008-12-18 | — | — | US | disclosed |
| US-7427617-B2 | Morpoline-bridged indazole derivatives | BAYER HEALTHCARE AG (DE) | 2008-09-23 | — | — | US | disclosed |
| US-7427617-B2 | Morpoline-bridged indazole derivatives | BAYER HEALTHCARE AG (DE) | 2008-09-23 | — | — | US | disclosed |
| US-20080194571-A1 | Acetylenic Piperazines as Metabotropic Glutamate Receptor Antagonists | ASTRAZENECA AB (SE) | 2008-08-14 | — | — | US | disclosed |
| US-20080194571-A1 | Acetylenic Piperazines as Metabotropic Glutamate Receptor Antagonists | ASTRAZENECA AB (SE) | 2008-08-14 | — | — | US | disclosed |
| US-7407645-B2 | Bioconjugates of metal complexes of nitrogen-containing macrocyclic ligands | METAPHORE PHARMACEUTICALS, INC. (US) | 2008-08-05 | — | — | US | disclosed |
| US-7407645-B2 | Bioconjugates of metal complexes of nitrogen-containing macrocyclic ligands | METAPHORE PHARMACEUTICALS, INC. (US) | 2008-08-05 | — | — | US | disclosed |
| US-7256186-B2 | Gamma secretase inhibitors | SCHERING CORPORATION (US) | 2007-08-14 | — | — | US | disclosed |
| US-7256186-B2 | Gamma secretase inhibitors | SCHERING CORPORATION (US) | 2007-08-14 | — | — | US | disclosed |
| US-7256186-B2 | Gamma secretase inhibitors | SCHERING CORPORATION (US) | 2007-08-14 | — | — | US | disclosed |
| US-7208602-B2 | Gamma secretase inhibitors | SCHERING CORPORATION (US) | 2007-04-24 | — | — | US | disclosed |
| US-7208602-B2 | Gamma secretase inhibitors | SCHERING CORPORATION (US) | 2007-04-24 | — | — | US | disclosed |
| US-7208602-B2 | Gamma secretase inhibitors | SCHERING CORPORATION (US) | 2007-04-24 | — | — | US | disclosed |
| US-7205401-B2 | Compositions and methods for separating amines and amino acids from their counter-enantiomers | IBC ADVANCED TECHNOLOGIES, INC. (US) | 2007-04-17 | — | — | US | disclosed |
| US-7205401-B2 | Compositions and methods for separating amines and amino acids from their counter-enantiomers | IBC ADVANCED TECHNOLOGIES, INC. (US) | 2007-04-17 | — | — | US | disclosed |
| WO-2007021575-A2 | ACETYLENIC PIPERAZINES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS | ASTRAZENECA AB (SE) | 2007-02-22 | — | — | WO | disclosed |
| WO-2007021574-A1 | BICYCLIC PIPERAZINES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS | ASTRAZENECA AB (SE) | 2007-02-22 | — | — | WO | disclosed |
| US-20070037816-A1 | Bicyclic piperazines as metabotropic glutatmate receptor antagonists | ASTRAZENECA AB (SE) | 2007-02-15 | — | — | US | disclosed |
| US-20070037817-A1 | Acetylenic piperazines as metabotropic glutamate receptor antagonists | ASTRAZENECA AB (SE) | 2007-02-15 | — | — | US | disclosed |
| US-20070037817-A1 | Acetylenic piperazines as metabotropic glutamate receptor antagonists | ASTRAZENECA AB (SE) | 2007-02-15 | — | — | US | disclosed |
| US-20070037816-A1 | Bicyclic piperazines as metabotropic glutatmate receptor antagonists | ASTRAZENECA AB (SE) | 2007-02-15 | — | — | US | disclosed |
| EP-1697344-A2 | HIV PROTEASE INHIBITING COMPOUNDS | ABBOTT LABORATORIES (US) | 2006-09-06 | — | — | EP | disclosed |
| US-20060128700-A1 | e.g. 2-[1-(2-Fluorobenzyl)-1H-indazol-3-yl]-5-(3-oxa-9-azabicyclo[3.3.1]non-9-yl)-4pyrimidinylamine; soluble guanylate cyclase stimulant; neurodegenerative diseases, cognition activator; Alhzeimer's, Parkinson's disease, Pick's syndrome, multiple sclerosis, HIV dementia, schizophrenia | BAYER HEALTHCARE AG (DE) | 2006-06-15 | — | — | US | disclosed |
| EP-1663975-A1 | NOVEL GAMMA SECRETASE INHIBITORS | SCHERING CORPORATION (US) | 2006-06-07 | — | — | EP | disclosed |
| US-20060100427-A1 | Novel Gamma Secretase inhibitors | SCHERING CORPORATION AND PHARMACOPEIA, INC. | 2006-05-11 | — | — | US | disclosed |
| WO-2004089903-A9 | PIPERIDINE DERIVATIVES AS RENIN INHIBITORS FOR THE TREATMENT OF HYPERTENSION | WARNER LAMBERT CO (US) | 2005-10-27 | — | — | WO | disclosed |
| US-20050148623-A1 | Prevent reproduct of aids virus | ABBVIE INC. | 2005-07-07 | — | — | US | disclosed |
| WO-2005058841-A2 | HIV PROTEASE INHIBITING COMPOUNDS | ABBOTT LABORATORIES (US) | 2005-06-30 | — | — | WO | disclosed |
| US-20050131017-A1 | HIV protease inhibiting compounds | ABBOTT LABORATORIES | 2005-06-16 | — | — | US | disclosed |
| US-20050085506-A1 | Novel gamma secretase inhibitors | SCHERING-PLOUGH CORPORATION AND PHARMACOPEIA, INC. | 2005-04-21 | — | — | US | disclosed |
| US-20050085506-A1 | Novel gamma secretase inhibitors | SCHERING-PLOUGH CORPORATION AND PHARMACOPEIA, INC. | 2005-04-21 | — | — | US | disclosed |
| US-20050085506-A1 | Novel gamma secretase inhibitors | SCHERING-PLOUGH CORPORATION AND PHARMACOPEIA, INC. | 2005-04-21 | — | — | US | disclosed |
| WO-2005028440-A1 | NOVEL GAMMA SECRETASE INHIBITORS | SCHERING CORPORATION (US) | 2005-03-31 | — | — | WO | disclosed |
| US-20040235863-A1 | Morpholine-bridged pyrazolopyridine derivatives | BAYER HEALTHCARE AG (DE) | 2004-11-25 | — | — | US | disclosed |
| EP-1472223-A1 | GAMMA SECRETASE INHIBITORS | SCHERING CORPORATION (US) | 2004-11-03 | — | — | EP | disclosed |
| US-20040204455-A1 | Piperidine derivative rennin inhibitors | WARNER-LAMBERT COMPANY LLC | 2004-10-14 | — | — | US | disclosed |
| US-20040171614-A1 | Novel gamma secretase inhibitors | SCHERING-PLOUGH CORPORATION | 2004-09-02 | — | — | US | disclosed |
| US-20040171614-A1 | Novel gamma secretase inhibitors | SCHERING-PLOUGH CORPORATION | 2004-09-02 | — | — | US | disclosed |
| US-20040171614-A1 | Novel gamma secretase inhibitors | SCHERING-PLOUGH CORPORATION | 2004-09-02 | — | — | US | disclosed |
| US-20040131550-A1 | Bioconjugates of metal complexes of nitrogen-containing macrocyclic ligands | METAPHORE PHARMACEUTICALS, INC. | 2004-07-08 | — | — | US | disclosed |
| US-20040057904-A1 | Methods of diagnostic image analysis using bioconjugates of metal complexes of nitrogen-containing macrocyclic ligands | METAPHORE PHARMACEUTICALS, INC. | 2004-03-25 | — | — | US | disclosed |
| US-20040048848-A1 | Novel gamma secretase inhibitors | SCHERING-PLOUGH CORPORATION AND PHARMACOPEIA, INC. | 2004-03-11 | — | — | US | disclosed |
| WO-2003066592-A1 | GAMMA SECRETASE INHIBITORS | SCHERING CORPORATION (US) | 2003-08-14 | — | — | WO | disclosed |
| US-6525041-B1 | Low molecular weight mimics of superoxide dismutase; inflammatory disorders, ischemic/reperfusion injury, stroke, atherosclerosis, and all other conditions of oxidant- induced tissue damage or injury | PHARMACIA CORPORATION | 2003-02-25 | — | — | US | disclosed |
| US-6176909-B1 | IN POLYMERIC BINDER | XEROX CORPORATION | 2001-01-23 | — | — | US | disclosed |
| US-6084093-A | SUBSTITUTED 1,4,7,10,13-PENTAAZACYCLOPENTADECANE MACROCYCLIC LIGANDS; MANGANESE COMPLEXES OF THE LIGAND ARE MIMICS OF SUPEROXIDE DISMUTASE; USEFUL AS THERAPEUTIC AGENTS FOR INFLAMMATORY DISEASES | G. D. SEARLE & CO. (US) | 2000-07-04 | — | — | US | disclosed |
| US-5976498-A | Methods of diagnostic image analysis using metal complexes of nitrogen-containing macrocyclic ligands | MONSANTO COMPANY | 1999-11-02 | — | — | US | disclosed |
| US-5939568-A | Accelerated catalysis of olefinic epoxidations | THE SCRIPPS RESEARCH INSTITUTE (US) | 1999-08-17 | — | — | US | disclosed |
| CN-1225631-A | Bioconjugates of manganese or iron complexes of nitrogen-contg. macrocyclic ligands effective as catalysis for dismutating superoxide | MONSANTO CO (US) | 1999-08-11 | — | — | CN | disclosed |
| US-5900344-A | Carrier composition and processes thereof | XEROX CORPORATION (US) | 1999-05-04 | — | — | US | disclosed |
| US-5874421-A | Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide | G. D. SEARLE & CO. (US) | 1999-02-23 | — | — | US | disclosed |
| EP-0891338-A1 | BIOCONJUGATES OF MANGANESE OR IRON COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS EFFECTIVE AS CATALYSTS FOR DISMUTATING SUPEROXIDE | MONSANTO COMPANY (US) | 1999-01-20 | — | — | EP | disclosed |
| EP-0888115-A1 | IRON COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS EFFECTIVE AS CATALYSTS FOR DISMUTATING SUPEROXIDE | MONSANTO COMPANY (US) | 1999-01-07 | — | — | EP | disclosed |
| CN-1200039-A | Bioconjugates of manganese complexes containing nitrogen macrocyclic ligand, and their application as catalysts of disproportionated super-oxide | MONSANTO CO (US) | 1998-11-25 | — | — | CN | disclosed |
| CN-1191530-A | Manganese or iron complexes of nitrogen-contg. macrocyclic ligands effective as catalysts for dismutating superoxide | MONSANTO CO (US) | 1998-08-26 | — | — | CN | disclosed |
| EP-0846003-A1 | METHODS OF DIAGNOSTIC IMAGE ANALYSIS USING BIOCONJUGATES OF METAL COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS | MONSANTO COMPANY (US) | 1998-06-10 | — | — | EP | disclosed |
| EP-0844889-A1 | METHODS OF DIAGNOSTIC IMAGE ANALYSIS USING METAL COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS | MONSANTO COMPANY (US) | 1998-06-03 | — | — | EP | disclosed |
| EP-0844886-A2 | BIOCONJUGATES OF MANGANESE COMPLEXES AND THEIR APPLICATION AS CATALYSTS | MONSANTO COMPANY (US) | 1998-06-03 | — | — | EP | disclosed |
| EP-0830352-A1 | MANGANESE OR IRON COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS EFFECTIVE AS CATALYSTS FOR DISMUTATING SUPEROXIDE | MONSANTO COMPANY (US) | 1998-03-25 | — | — | EP | disclosed |
| EP-0598753-B1 | MANGANESE COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS EFFECTIVE AS CATALYSTS FOR DISMUTATING SUPEROXIDE | MONSANTO CO (US) | 1998-03-18 | — | — | EP | disclosed |
| WO-1997033588-A9 | IRON COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS EFFECTIVE AS CATALYSTS FOR DISMUTATING SUPEROXIDE | — | 1997-11-06 | — | — | WO | disclosed |
| WO-1997033588-A1 | IRON COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS EFFECTIVE AS CATALYSTS FOR DISMUTATING SUPEROXIDE | MONSANTO COMPANY (US) | 1997-09-18 | — | — | WO | disclosed |
| WO-1997033877-A1 | BIOCONJUGATES OF MANGANESE OR IRON COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS EFFECTIVE AS CATALYSTS FOR DISMUTATING SUPEROXIDE | MONSANTO COMPANY (US) | 1997-09-18 | — | — | WO | disclosed |
| US-5637578-A | AGENTS FOR INFLAMMATION, ISCHEMIC/REPERFUSION INJURY, STROKE, ATHEROSCLEROSIS, AND HYPERTENSION | MONSANTO COMPANY | 1997-06-10 | — | — | US | disclosed |
| US-5610293-A | TREATMENT OF INFLAMMATORY DISEASES, ISCHEMIC/REPERFUSION INJURY, STROKE, ATHERSCLEROSIS, HYPERTENSION | MONSANTO COMPANY (US) | 1997-03-11 | — | — | US | disclosed |
| WO-1997006830-A1 | METHODS OF DIAGNOSTIC IMAGE ANALYSIS USING BIOCONJUGATES OF METAL COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS | MONSANTO COMPANY (US) | 1997-02-27 | — | — | WO | disclosed |
| WO-1997006831-A1 | METHODS OF DIAGNOSTIC IMAGE ANALYSIS USING METAL COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS | MONSANTO COMPANY (US) | 1997-02-27 | — | — | WO | disclosed |
| WO-1997006824-A2 | BIOCONJUGATES OF MANGANESE COMPLEXES AND THEIR APPLICATION AS CATALYSTS | MONSANTO COMPANY (US) | 1997-02-27 | — | — | WO | disclosed |
| WO-1996039396-A1 | MANGANESE OR IRON COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS EFFECTIVE AS CATALYSTS FOR DISMUTATING SUPEROXIDE | MONSANTO COMPANY (US) | 1996-12-12 | — | — | WO | disclosed |
| WO-1995001346-A1 | CHELATING COMPOUNDS | AKZO NOBEL N.V. (NL) | 1995-01-12 | — | — | WO | disclosed |
| EP-0598753-A1 | MANGANESE COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS EFFECTIVE AS CATALYSTS FOR DISMUTATING SUPEROXIDE | MONSANTO COMPANY (US) | 1994-06-01 | — | — | EP | disclosed |
| US-5234946-A | Anticholesterol, antilipemic | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1993-08-10 | — | — | US | disclosed |
| EP-0267794-B1 | PROCESS FOR PREPARING POLYOLEFINS | Nippon Petrochemicals Co., Ltd. (JP) | 1993-05-05 | — | — | EP | disclosed |
| WO-1993002090-A1 | MANGANESE COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS EFFECTIVE AS CATALYSTS FOR DISMUTATING SUPEROXIDE | MONSANTO COMPANY (US) | 1993-02-04 | — | — | WO | disclosed |
| EP-0524161-A1 | Manganese complexes of nitrogen containing macrocyclic ligands effective as catalysts for dismutating superoxide | MONSANTO COMPANY (US) | 1993-01-20 | — | — | EP | disclosed |
| EP-0395768-A1 | SUBSTITUTED ALLYLAMINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1990-11-07 | — | — | EP | disclosed |
| EP-0267794-A2 | Process for preparing polyolefins | Nippon Petrochemicals Co., Ltd. (JP) | 1988-05-18 | — | — | EP | disclosed |
| EP-0052471-B1 | PROCESS AND CATALYST FOR POLYMERIZATION OF OLEFINS | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1985-09-18 | — | — | EP | disclosed |
| US-4526941-A | Contacting alpha olefin with catalyst comprising organomagnesium compound, titanium compound, nitrogen or sulfur heterocyclic compound, slurry component and organometallic component | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1985-07-02 | — | — | US | disclosed |
| US-4525555-A | TITANIUM COMPOUND SUPPORTED ON SOLID REACTION PRODUCT OF MAGNESIUM HALIDE, SILOXANES, ORGANIC COMPOUNDS | NIPPON OIL COMPANY, LIMITED (JP) | 1985-06-25 | — | — | US | disclosed |
| EP-0052471-A1 | Process and catalyst for polymerization of olefins | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1982-05-26 | — | — | EP | disclosed |
| US-4330650-A | HAVING MAGNESIUM COMPONENTS, TITANIUM COMPONENTS, ORGANOALUMINUM COMPONENTS AND HETEROCYCLIC CARBOXYLIC ESTER ELECTRON DONOR COMPONENTS | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1982-05-18 | — | — | US | disclosed |
| US-4255280-A | ORGANOMAGNESIUM, CHLOROSILANE, TITANIUM, ORGANOMETALLIC AND HETEROCYCLIC ESTER COMPONENTS | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1981-03-10 | — | — | US | disclosed |
| US-4255280-A | ORGANOMAGNESIUM, CHLOROSILANE, TITANIUM, ORGANOMETALLIC AND HETEROCYCLIC ESTER COMPONENTS | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1981-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (50 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080312240-A1 | Bicyclic Piperazines as Metabotropic Glutatmate Receptor Antagonists | GRM5, GRM1, GRIN1 | MAPT 1281/4885CYP1A2 2506/4885SMN1; SMN2 1171/4885 |
| US-20170240485-A1 | Synthesis of Esters by Functionalisation of CO2 | C1S, C9, C5 | MAPT 4795/4885CYP1A2 132/4885SMN1; SMN2 2568/4885 |
| US-20120245341-A1 | AROMATIC COMPOUND, MODIFICATION CARRIER THAT USES SAME AND IS USED FOR SYNTHESIZING AN OLIGONUCLEOTIDE DERIVATIVE, OLIGONUCLEOTIDE DERIVATIVE, AND OLIGONUCLEOTIDE CONSTRUCT | NSUN2, SLCO2A1, ABCB7 | MAPT 4603/4885CYP1A2 1848/4885SMN1; SMN2 1074/4885 |
| US-11840521-B2 | Modulators of Mas-related G-protein receptor X4 and related products and methods | MRGPRX4, MRGPRX1, MRGPRX2 | MAPT 4238/4885CYP1A2 2025/4885SMN1; SMN2 4483/4885 |
| US-20240308962-A1 | TRACERS FOR PETROLEUM RESERVOIRS | TRPA1, NPC1L1, TMEM14C | MAPT 1129/4885CYP1A2 2637/4885SMN1; SMN2 2553/4885 |
| US-20050148623-A1 | Prevent reproduct of aids virus | SERPINB1, PRSS1, SERPINA3 | MAPT 1745/4885CYP1A2 920/4885SMN1; SMN2 4019/4885 |
| US-20040171614-A1 | Novel gamma secretase inhibitors | BACE1, BACE2, APP | MAPT 1758/4885CYP1A2 1966/4885SMN1; SMN2 3205/4885 |
| US-20220170362-A1 | TRACERS FOR PETROLEUM RESERVOIRS | TRPA1, NPC1L1, TMEM14C | MAPT 1129/4885CYP1A2 2637/4885SMN1; SMN2 2553/4885 |
| US-12384747-B2 | Tracers for petroleum reservoirs | TRPA1, NPC1L1, TMEM14C | MAPT 1129/4885CYP1A2 2637/4885SMN1; SMN2 2553/4885 |
| US-20220160908-A1 | CHELATORS AND METHODS OF MAKING AND USING SAME | TFRC, SLC40A1, FOLH1 | MAPT 4292/4885CYP1A2 4245/4885SMN1; SMN2 3080/4885 |
| US-12077504-B2 | Tracers for petroleum reservoirs | TRPA1, NPC1L1, TMEM14C | MAPT 1138/4885CYP1A2 2638/4885SMN1; SMN2 2520/4885 |
| US-20180354929-A1 | SUBSTITUTED HETEROARYL ALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION | HBB, HBG2, MB | MAPT 4773/4885CYP1A2 229/4885SMN1; SMN2 858/4885 |
| US-20090023717-A1 | MORPHINE-BRIDGED INDAZOLE DERIVATIVES | OPRM1, OPRK1, OPRD1 | MAPT 1288/4885CYP1A2 216/4885SMN1; SMN2 704/4885 |
| US-20250057990-A1 | TISSUE-SPECIFIC MANGANESE BASED MRI CONTRAST AGENTS | TFRC, MTPN, MYADM | MAPT 469/4885CYP1A2 4753/4885SMN1; SMN2 71/4885 |
| US-20240067606-A1 | TRACERS FOR PETROLEUM RESERVOIRS | TRPA1, NPC1L1, TMEM14C | MAPT 1138/4885CYP1A2 2660/4885SMN1; SMN2 2627/4885 |
| US-20120178776-A1 | DIHYDRONAPHTHYRIDINYL(ORGANO)METHANONE ANALOGS AS POSITIVE ALLOSTERIC MGLUR5 MODULATORS | GRM5, GRIK5, GRM3 | MAPT 528/4885CYP1A2 3084/4885SMN1; SMN2 2012/4885 |
| US-20160037034-A1 | NEAR-INFRARED-RAY-ABSORBING COMPOSITION, NEAR-INFRARED-RAY CUT FILTER USING SAME, MANUFACTURING METHOD THEREFOR, CAMERA MODULE, AND MANUFACTURING METHOD THEREFOR | FAR1, SLC39A11, NOTUM | MAPT 664/4885CYP1A2 1493/4885SMN1; SMN2 3862/4885 |
| US-20110224343-A1 | MODIFIER FOR AROMATIC POLYESTER AND AROMATIC POLYESTER RESIN COMPOSITION COMPRISING THE SAME | F12, PHAX, WDR82 | MAPT 1923/4885CYP1A2 2262/4885SMN1; SMN2 4357/4885 |
| US-11230919-B2 | Tracers for petroleum reservoirs | TRPA1, NPC1L1, TMEM14C | MAPT 1129/4885CYP1A2 2637/4885SMN1; SMN2 2553/4885 |
| US-12410134-B2 | Tracers for petroleum reservoirs | TRPA1, NPC1L1, TMEM14C | MAPT 1138/4885CYP1A2 2660/4885SMN1; SMN2 2627/4885 |
| US-10696694-B2 | Lanthanide complexes for crystallising biological macromolecules and determining the crystallographic structure thereof | SSB, F12, LGALS1 | MAPT 1921/4885CYP1A2 4414/4885SMN1; SMN2 3236/4885 |
| US-20220125944-A1 | ANTIBODY-DRUG CONJUGATE AND USE THEREOF | CSGALNACT1, GALNT14, GALNT1 | MAPT 340/4885CYP1A2 292/4885SMN1; SMN2 4306/4885 |
| US-20040048848-A1 | Novel gamma secretase inhibitors | BACE1, BACE2, PSEN1 | MAPT 314/4885CYP1A2 1201/4885SMN1; SMN2 3050/4885 |
| US-20110313130-A1 | BIFUNCTIONAL CHELATING AGENTS | FCGRT, C1QBP, H1-2 | MAPT 3598/4885CYP1A2 2997/4885SMN1; SMN2 2139/4885 |
| US-20070037817-A1 | Acetylenic piperazines as metabotropic glutamate receptor antagonists | GRM1, GRM5, GRIN1 | MAPT 1692/4885CYP1A2 2665/4885SMN1; SMN2 1774/4885 |
| US-10717752-B2 | Dehydrogenative silylation, hydrosilylation and crosslinking using pyridinediimine cobalt carboxylate catalysts | YAP1, CTCF, SIRT3 | MAPT 4345/4885CYP1A2 537/4885SMN1; SMN2 2417/4885 |
| US-11643399-B2 | Modulators of mas-related G-protein receptor X4 and related products and methods | MRGPRX4, MRGPRX1, MRGPRX2 | MAPT 4238/4885CYP1A2 2025/4885SMN1; SMN2 4483/4885 |
| US-20210032213-A1 | MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS | MRGPRX4, MRGPRX1, MRGPRX2 | MAPT 4235/4885CYP1A2 1975/4885SMN1; SMN2 4469/4885 |
| US-20040131550-A1 | Bioconjugates of metal complexes of nitrogen-containing macrocyclic ligands | RXFP3, RXFP1, RCN1 | MAPT 4076/4885CYP1A2 4279/4885SMN1; SMN2 2989/4885 |
| US-20060128700-A1 | e.g. 2-[1-(2-Fluorobenzyl)-1H-indazol-3-yl]-5-(3-oxa-9-azabicyclo[3.3.1]non-9-yl)-4pyrimidinylamine; soluble guanylate cyclase stimulant; neurodegenerative diseases, cognition activator; Alhzeimer's, Parkinson's disease, Pick's syndrome, multiple sclerosis, HIV dementia, schizophrenia | GUCY1B2, COG4, GUCY1A2 | MAPT 476/4885CYP1A2 3366/4885SMN1; SMN2 569/4885 |
| US-20190226326-A1 | TRACERS FOR PETROLEUM RESERVOIRS | TRPA1, NPC1L1, TMEM14C | MAPT 1138/4885CYP1A2 2638/4885SMN1; SMN2 2520/4885 |
| US-20080194571-A1 | Acetylenic Piperazines as Metabotropic Glutamate Receptor Antagonists | GRM1, GRM5, GRIN1 | MAPT 1692/4885CYP1A2 2665/4885SMN1; SMN2 1774/4885 |
| US-20040204455-A1 | Piperidine derivative rennin inhibitors | REN, ACE, HPN | MAPT 1330/4885CYP1A2 2821/4885SMN1; SMN2 4290/4885 |
| US-20260108482-A1 | MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS | MRGPRX4, MRGPRX1, MRGPRX2 | MAPT 4716/4885CYP1A2 1885/4885SMN1; SMN2 4376/4885 |
| US-20230184099-A1 | TRACERS FOR PETROLEUM RESERVOIRS | TRPA1, NPC1L1, TMEM14C | MAPT 1138/4885CYP1A2 2638/4885SMN1; SMN2 2520/4885 |
| US-20090203657-A1 | Dual Pharmacophores - PDE4-Muscarinic Antagonistics | PDE4A, PDE1A, PDE4B | MAPT 4071/4885CYP1A2 114/4885SMN1; SMN2 2601/4885 |
| US-20210161887-A1 | Novel Hydrazone Derivatives For Preventing Or Treating EBV-Related Cancers | RB1, MALT1, NR3C1 | MAPT 3565/4885CYP1A2 1307/4885SMN1; SMN2 3897/4885 |
| US-20040057904-A1 | Methods of diagnostic image analysis using bioconjugates of metal complexes of nitrogen-containing macrocyclic ligands | RCN1, RXFP3, TFRC | MAPT 3620/4885CYP1A2 4620/4885SMN1; SMN2 2778/4885 |
| US-20180290999-A1 | PROCESSES FOR MAKING TRIAZOLO[4,5D] PYRAMIDINE DERIVATIVES AND INTERMEDIATES THEREOF | IL5, THPO, PPOX | MAPT 1251/4885CYP1A2 162/4885SMN1; SMN2 1600/4885 |
| US-20120172391-A1 | NAPHTHYRIDINONE ANALOGS AS MGLUR5 POSITIVE ALLOSTERIC MODULATORS | GRM5, GRIK5, GRM1 | MAPT 562/4885CYP1A2 3633/4885SMN1; SMN2 1587/4885 |
| US-20200190058-A1 | SUBSTITUTED HETEROARYL ALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION | HBB, HBG2, MB | MAPT 4773/4885CYP1A2 229/4885SMN1; SMN2 858/4885 |
| US-20250346561-A1 | TRACERS FOR PETROLEUM RESERVOIRS | TRPA1, NPC1L1, TMEM14C | MAPT 1129/4885CYP1A2 2637/4885SMN1; SMN2 2553/4885 |
| US-11827604-B2 | Tracers for petroleum reservoirs | TRPA1, NPC1L1, TMEM14C | MAPT 1129/4885CYP1A2 2637/4885SMN1; SMN2 2553/4885 |
| US-20180201634-A1 | DEHYDROGENATIVE SILYLATION, HYDROSILYLATION AND CROSSLINKING USING PYRIDINEDIIMINE COBALT CARBOXYLATE CATALYSTS | YAP1, CTCF, SIRT3 | MAPT 4345/4885CYP1A2 537/4885SMN1; SMN2 2417/4885 |
| US-20140187527-A1 | Macrocyclic Compounds And Metal Complexes For Bioimaging And Biomedical Applications | DNASE1L3, DNASE1, SNRPA | MAPT 3117/4885CYP1A2 4667/4885SMN1; SMN2 1067/4885 |
| US-20060100427-A1 | Novel Gamma Secretase inhibitors | BACE1, BACE2, PSEN1 | MAPT 368/4885CYP1A2 948/4885SMN1; SMN2 3267/4885 |
| US-12577247-B2 | Diaminopyrazolo[1,5-a]pyrimidine-6-carbonitrile compounds as adenosine 2A receptor and adenosine 2B receptor antagonist | ADORA1, ADORA3, ADORA2A | MAPT 3965/4885CYP1A2 168/4885SMN1; SMN2 4360/4885 |
| US-10822326-B2 | Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation | HBB, HBG2, MB | MAPT 4773/4885CYP1A2 229/4885SMN1; SMN2 858/4885 |
| US-20090098047-A1 | BIOCONJUGATES OF METAL COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS | RXFP3, RXFP1, C3AR1 | MAPT 4135/4885CYP1A2 4422/4885SMN1; SMN2 3106/4885 |
| US-20230364070-A1 | PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER | ERBB2, EGFR, ERBB3 | MAPT 1075/4885CYP1A2 1747/4885SMN1; SMN2 3294/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.